Drug
Desmoteplase
Desmoteplase: highest development phase Phase 3, developed by Lundbeck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Lundbeck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Desmoteplase NCT00856661 | Phase 3 | Stroke |
Latest
No recent events.
Follow Desmoteplase on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.